Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Caprylocaproyl macrogolglycerides increase absorption of intranasal migraine treatment

Oct. 27, 2000

Researchers discover potential new target for antidepressant drugs

Oct. 26, 2000

Caspase 3 inhibitors from Merck Frosst demonstrate antiischemic activity

Oct. 26, 2000

Novel treatments for labor pain revealed in recent patent by AstraZeneca

Oct. 26, 2000

Organon characterizes water-soluble general anesthetic advanced to early clinical trials

Oct. 26, 2000

Bradykinin B2 antagonist effective in rat model of head trauma

Oct. 26, 2000

ASA 2000: binding, functional and physicochemical properties of TRK-820 and TAN-684

Oct. 26, 2000

Human studies confirm excellent safety and suitable pharmacokinetics of parecoxib

Oct. 26, 2000

LF-16-0687MS reduces brain edema and neurological severity scores in closed head trauma

Oct. 26, 2000

Delta opioid receptor ligands and potential therapeutic uses

Oct. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...